Global Complement Drug Market Growth (Status and Outlook) 2025-2031

April 2025 | 134 pages | ID: GD8847885E63EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Pneumatic Ballistic Shockwave Therapy Devices market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

In The Field Of Clinical Medicine, Shock Wave Was First Used In Extracorporeal Shock Wave Lithotripsy. In The Late 1980s, Extracorporeal Shock Wave Lithotripsy Technology Began To Be Applied To The Field Of Orthopedics And Rehabilitation Physiotherapy. After More Than Ten Years Of Clinical Research, Shock Wave Therapy Has Become Increasingly Perfect. The Range Of Applications Is Also Expanding.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LP Information, Inc. (LPI) ' newest research report, the “Pneumatic Ballistic Shockwave Therapy Devices Industry Forecast” looks at past sales and reviews total world Pneumatic Ballistic Shockwave Therapy Devices sales in 2024, providing a comprehensive analysis by region and market sector of projected Pneumatic Ballistic Shockwave Therapy Devices sales for 2025 through 2031. With Pneumatic Ballistic Shockwave Therapy Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pneumatic Ballistic Shockwave Therapy Devices industry.

This Insight Report provides a comprehensive analysis of the global Pneumatic Ballistic Shockwave Therapy Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pneumatic Ballistic Shockwave Therapy Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pneumatic Ballistic Shockwave Therapy Devices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pneumatic Ballistic Shockwave Therapy Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pneumatic Ballistic Shockwave Therapy Devices.

This report presents a comprehensive overview, market shares, and growth opportunities of Pneumatic Ballistic Shockwave Therapy Devices market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Focused Therapy Devices
• Radiation Therapy Devices

Segmentation by Application:

• Hospitals
• Clinics
• Physiotherapy Centers
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Boston Scientific Corporation
• C.R. Bard Inc.
• Dornier MedTech GmbH
• Lumenis Ltd.
• Medtrue Enterprise
• Olympus Corporation
• Cook Group
• Edaptms TMS
• Siemens AG
• Karl Storz
• STORZ Medical
• Medispec
• Astar
• Chattanooga International
• DermoEquipos
• Hubei Oj Electronic Technology
• Chongqing Seri Technology
• Shanghai Lumsail Industrial Inc.
• GUANGZHOU POTENT MEDICAL EQUIPMENT JOINT-STOCK

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pneumatic Ballistic Shockwave Therapy Devices market?

What factors are driving Pneumatic Ballistic Shockwave Therapy Devices market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pneumatic Ballistic Shockwave Therapy Devices market opportunities vary by end market size?

How does Pneumatic Ballistic Shockwave Therapy Devices break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Complement Drug Market Size (2020-2031)
  2.1.2 Complement Drug Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Complement Drug by Country/Region (2020, 2024 & 2031)
2.2 Complement Drug Segment by Type
  2.2.1 Peptides
  2.2.2 Antibodies
  2.2.3 Others
2.3 Complement Drug Market Size by Type
  2.3.1 Complement Drug Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Complement Drug Market Size Market Share by Type (2020-2025)
2.4 Complement Drug Segment by Application
  2.4.1 Blood Disease
  2.4.2 Kidney Disease
  2.4.3 Others
2.5 Complement Drug Market Size by Application
  2.5.1 Complement Drug Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Complement Drug Market Size Market Share by Application (2020-2025)

3 COMPLEMENT DRUG MARKET SIZE BY PLAYER

3.1 Complement Drug Market Size Market Share by Player
  3.1.1 Global Complement Drug Revenue by Player (2020-2025)
  3.1.2 Global Complement Drug Revenue Market Share by Player (2020-2025)
3.2 Global Complement Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 COMPLEMENT DRUG BY REGION

4.1 Complement Drug Market Size by Region (2020-2025)
4.2 Global Complement Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Complement Drug Market Size Growth (2020-2025)
4.4 APAC Complement Drug Market Size Growth (2020-2025)
4.5 Europe Complement Drug Market Size Growth (2020-2025)
4.6 Middle East & Africa Complement Drug Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Complement Drug Market Size by Country (2020-2025)
5.2 Americas Complement Drug Market Size by Type (2020-2025)
5.3 Americas Complement Drug Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Complement Drug Market Size by Region (2020-2025)
6.2 APAC Complement Drug Market Size by Type (2020-2025)
6.3 APAC Complement Drug Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Complement Drug Market Size by Country (2020-2025)
7.2 Europe Complement Drug Market Size by Type (2020-2025)
7.3 Europe Complement Drug Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Complement Drug by Region (2020-2025)
8.2 Middle East & Africa Complement Drug Market Size by Type (2020-2025)
8.3 Middle East & Africa Complement Drug Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL COMPLEMENT DRUG MARKET FORECAST

10.1 Global Complement Drug Forecast by Region (2026-2031)
  10.1.1 Global Complement Drug Forecast by Region (2026-2031)
  10.1.2 Americas Complement Drug Forecast
  10.1.3 APAC Complement Drug Forecast
  10.1.4 Europe Complement Drug Forecast
  10.1.5 Middle East & Africa Complement Drug Forecast
10.2 Americas Complement Drug Forecast by Country (2026-2031)
  10.2.1 United States Market Complement Drug Forecast
  10.2.2 Canada Market Complement Drug Forecast
  10.2.3 Mexico Market Complement Drug Forecast
  10.2.4 Brazil Market Complement Drug Forecast
10.3 APAC Complement Drug Forecast by Region (2026-2031)
  10.3.1 China Complement Drug Market Forecast
  10.3.2 Japan Market Complement Drug Forecast
  10.3.3 Korea Market Complement Drug Forecast
  10.3.4 Southeast Asia Market Complement Drug Forecast
  10.3.5 India Market Complement Drug Forecast
  10.3.6 Australia Market Complement Drug Forecast
10.4 Europe Complement Drug Forecast by Country (2026-2031)
  10.4.1 Germany Market Complement Drug Forecast
  10.4.2 France Market Complement Drug Forecast
  10.4.3 UK Market Complement Drug Forecast
  10.4.4 Italy Market Complement Drug Forecast
  10.4.5 Russia Market Complement Drug Forecast
10.5 Middle East & Africa Complement Drug Forecast by Region (2026-2031)
  10.5.1 Egypt Market Complement Drug Forecast
  10.5.2 South Africa Market Complement Drug Forecast
  10.5.3 Israel Market Complement Drug Forecast
  10.5.4 Turkey Market Complement Drug Forecast
10.6 Global Complement Drug Forecast by Type (2026-2031)
10.7 Global Complement Drug Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Complement Drug Forecast

11 KEY PLAYERS ANALYSIS

11.1 Novartis AG
  11.1.1 Novartis AG Company Information
  11.1.2 Novartis AG Complement Drug Product Offered
  11.1.3 Novartis AG Complement Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Novartis AG Main Business Overview
  11.1.5 Novartis AG Latest Developments
11.2 Alexion Pharmaceuticals
  11.2.1 Alexion Pharmaceuticals Company Information
  11.2.2 Alexion Pharmaceuticals Complement Drug Product Offered
  11.2.3 Alexion Pharmaceuticals Complement Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Alexion Pharmaceuticals Main Business Overview
  11.2.5 Alexion Pharmaceuticals Latest Developments
11.3 ChemoCentryx
  11.3.1 ChemoCentryx Company Information
  11.3.2 ChemoCentryx Complement Drug Product Offered
  11.3.3 ChemoCentryx Complement Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 ChemoCentryx Main Business Overview
  11.3.5 ChemoCentryx Latest Developments
11.4 Roche
  11.4.1 Roche Company Information
  11.4.2 Roche Complement Drug Product Offered
  11.4.3 Roche Complement Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Roche Main Business Overview
  11.4.5 Roche Latest Developments
11.5 Apellis
  11.5.1 Apellis Company Information
  11.5.2 Apellis Complement Drug Product Offered
  11.5.3 Apellis Complement Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Apellis Main Business Overview
  11.5.5 Apellis Latest Developments
11.6 Regeneron
  11.6.1 Regeneron Company Information
  11.6.2 Regeneron Complement Drug Product Offered
  11.6.3 Regeneron Complement Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Regeneron Main Business Overview
  11.6.5 Regeneron Latest Developments
11.7 Amgen
  11.7.1 Amgen Company Information
  11.7.2 Amgen Complement Drug Product Offered
  11.7.3 Amgen Complement Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Amgen Main Business Overview
  11.7.5 Amgen Latest Developments
11.8 Alnylam
  11.8.1 Alnylam Company Information
  11.8.2 Alnylam Complement Drug Product Offered
  11.8.3 Alnylam Complement Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Alnylam Main Business Overview
  11.8.5 Alnylam Latest Developments
11.9 UCB
  11.9.1 UCB Company Information
  11.9.2 UCB Complement Drug Product Offered
  11.9.3 UCB Complement Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 UCB Main Business Overview
  11.9.5 UCB Latest Developments
11.10 InflaRx
  11.10.1 InflaRx Company Information
  11.10.2 InflaRx Complement Drug Product Offered
  11.10.3 InflaRx Complement Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 InflaRx Main Business Overview
  11.10.5 InflaRx Latest Developments
11.11 ChemoCentryx
  11.11.1 ChemoCentryx Company Information
  11.11.2 ChemoCentryx Complement Drug Product Offered
  11.11.3 ChemoCentryx Complement Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 ChemoCentryx Main Business Overview
  11.11.5 ChemoCentryx Latest Developments
11.12 Innate Pharma
  11.12.1 Innate Pharma Company Information
  11.12.2 Innate Pharma Complement Drug Product Offered
  11.12.3 Innate Pharma Complement Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Innate Pharma Main Business Overview
  11.12.5 Innate Pharma Latest Developments
11.13 Ionis Pharmaceuticals
  11.13.1 Ionis Pharmaceuticals Company Information
  11.13.2 Ionis Pharmaceuticals Complement Drug Product Offered
  11.13.3 Ionis Pharmaceuticals Complement Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Ionis Pharmaceuticals Main Business Overview
  11.13.5 Ionis Pharmaceuticals Latest Developments
11.14 Avant Immunotherapeutics
  11.14.1 Avant Immunotherapeutics Company Information
  11.14.2 Avant Immunotherapeutics Complement Drug Product Offered
  11.14.3 Avant Immunotherapeutics Complement Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.14.4 Avant Immunotherapeutics Main Business Overview
  11.14.5 Avant Immunotherapeutics Latest Developments
11.15 Pfizer
  11.15.1 Pfizer Company Information
  11.15.2 Pfizer Complement Drug Product Offered
  11.15.3 Pfizer Complement Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.15.4 Pfizer Main Business Overview
  11.15.5 Pfizer Latest Developments
11.16 Sanofi
  11.16.1 Sanofi Company Information
  11.16.2 Sanofi Complement Drug Product Offered
  11.16.3 Sanofi Complement Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.16.4 Sanofi Main Business Overview
  11.16.5 Sanofi Latest Developments
11.17 Omeros
  11.17.1 Omeros Company Information
  11.17.2 Omeros Complement Drug Product Offered
  11.17.3 Omeros Complement Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.17.4 Omeros Main Business Overview
  11.17.5 Omeros Latest Developments
11.18 GenMab
  11.18.1 GenMab Company Information
  11.18.2 GenMab Complement Drug Product Offered
  11.18.3 GenMab Complement Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.18.4 GenMab Main Business Overview
  11.18.5 GenMab Latest Developments
11.19 Akari Therapeutics
  11.19.1 Akari Therapeutics Company Information
  11.19.2 Akari Therapeutics Complement Drug Product Offered
  11.19.3 Akari Therapeutics Complement Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.19.4 Akari Therapeutics Main Business Overview
  11.19.5 Akari Therapeutics Latest Developments
11.20 AbbVie
  11.20.1 AbbVie Company Information
  11.20.2 AbbVie Complement Drug Product Offered
  11.20.3 AbbVie Complement Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.20.4 AbbVie Main Business Overview
  11.20.5 AbbVie Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Complement Drug Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Complement Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Peptides
Table 4. Major Players of Antibodies
Table 5. Major Players of Others
Table 6. Complement Drug Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Complement Drug Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Complement Drug Market Size Market Share by Type (2020-2025)
Table 9. Complement Drug Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Complement Drug Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Complement Drug Market Size Market Share by Application (2020-2025)
Table 12. Global Complement Drug Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Complement Drug Revenue Market Share by Player (2020-2025)
Table 14. Complement Drug Key Players Head office and Products Offered
Table 15. Complement Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Complement Drug Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Complement Drug Market Size Market Share by Region (2020-2025)
Table 20. Global Complement Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Complement Drug Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Complement Drug Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Complement Drug Market Size Market Share by Country (2020-2025)
Table 24. Americas Complement Drug Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Complement Drug Market Size Market Share by Type (2020-2025)
Table 26. Americas Complement Drug Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Complement Drug Market Size Market Share by Application (2020-2025)
Table 28. APAC Complement Drug Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Complement Drug Market Size Market Share by Region (2020-2025)
Table 30. APAC Complement Drug Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Complement Drug Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Complement Drug Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Complement Drug Market Size Market Share by Country (2020-2025)
Table 34. Europe Complement Drug Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Complement Drug Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Complement Drug Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Complement Drug Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Complement Drug Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Complement Drug
Table 40. Key Market Challenges & Risks of Complement Drug
Table 41. Key Industry Trends of Complement Drug
Table 42. Global Complement Drug Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Complement Drug Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Complement Drug Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Complement Drug Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Novartis AG Details, Company Type, Complement Drug Area Served and Its Competitors
Table 47. Novartis AG Complement Drug Product Offered
Table 48. Novartis AG Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Novartis AG Main Business
Table 50. Novartis AG Latest Developments
Table 51. Alexion Pharmaceuticals Details, Company Type, Complement Drug Area Served and Its Competitors
Table 52. Alexion Pharmaceuticals Complement Drug Product Offered
Table 53. Alexion Pharmaceuticals Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Alexion Pharmaceuticals Main Business
Table 55. Alexion Pharmaceuticals Latest Developments
Table 56. ChemoCentryx Details, Company Type, Complement Drug Area Served and Its Competitors
Table 57. ChemoCentryx Complement Drug Product Offered
Table 58. ChemoCentryx Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. ChemoCentryx Main Business
Table 60. ChemoCentryx Latest Developments
Table 61. Roche Details, Company Type, Complement Drug Area Served and Its Competitors
Table 62. Roche Complement Drug Product Offered
Table 63. Roche Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Roche Main Business
Table 65. Roche Latest Developments
Table 66. Apellis Details, Company Type, Complement Drug Area Served and Its Competitors
Table 67. Apellis Complement Drug Product Offered
Table 68. Apellis Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Apellis Main Business
Table 70. Apellis Latest Developments
Table 71. Regeneron Details, Company Type, Complement Drug Area Served and Its Competitors
Table 72. Regeneron Complement Drug Product Offered
Table 73. Regeneron Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Regeneron Main Business
Table 75. Regeneron Latest Developments
Table 76. Amgen Details, Company Type, Complement Drug Area Served and Its Competitors
Table 77. Amgen Complement Drug Product Offered
Table 78. Amgen Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Amgen Main Business
Table 80. Amgen Latest Developments
Table 81. Alnylam Details, Company Type, Complement Drug Area Served and Its Competitors
Table 82. Alnylam Complement Drug Product Offered
Table 83. Alnylam Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Alnylam Main Business
Table 85. Alnylam Latest Developments
Table 86. UCB Details, Company Type, Complement Drug Area Served and Its Competitors
Table 87. UCB Complement Drug Product Offered
Table 88. UCB Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. UCB Main Business
Table 90. UCB Latest Developments
Table 91. InflaRx Details, Company Type, Complement Drug Area Served and Its Competitors
Table 92. InflaRx Complement Drug Product Offered
Table 93. InflaRx Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. InflaRx Main Business
Table 95. InflaRx Latest Developments
Table 96. ChemoCentryx Details, Company Type, Complement Drug Area Served and Its Competitors
Table 97. ChemoCentryx Complement Drug Product Offered
Table 98. ChemoCentryx Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. ChemoCentryx Main Business
Table 100. ChemoCentryx Latest Developments
Table 101. Innate Pharma Details, Company Type, Complement Drug Area Served and Its Competitors
Table 102. Innate Pharma Complement Drug Product Offered
Table 103. Innate Pharma Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Innate Pharma Main Business
Table 105. Innate Pharma Latest Developments
Table 106. Ionis Pharmaceuticals Details, Company Type, Complement Drug Area Served and Its Competitors
Table 107. Ionis Pharmaceuticals Complement Drug Product Offered
Table 108. Ionis Pharmaceuticals Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. Ionis Pharmaceuticals Main Business
Table 110. Ionis Pharmaceuticals Latest Developments
Table 111. Avant Immunotherapeutics Details, Company Type, Complement Drug Area Served and Its Competitors
Table 112. Avant Immunotherapeutics Complement Drug Product Offered
Table 113. Avant Immunotherapeutics Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. Avant Immunotherapeutics Main Business
Table 115. Avant Immunotherapeutics Latest Developments
Table 116. Pfizer Details, Company Type, Complement Drug Area Served and Its Competitors
Table 117. Pfizer Complement Drug Product Offered
Table 118. Pfizer Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 119. Pfizer Main Business
Table 120. Pfizer Latest Developments
Table 121. Sanofi Details, Company Type, Complement Drug Area Served and Its Competitors
Table 122. Sanofi Complement Drug Product Offered
Table 123. Sanofi Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 124. Sanofi Main Business
Table 125. Sanofi Latest Developments
Table 126. Omeros Details, Company Type, Complement Drug Area Served and Its Competitors
Table 127. Omeros Complement Drug Product Offered
Table 128. Omeros Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 129. Omeros Main Business
Table 130. Omeros Latest Developments
Table 131. GenMab Details, Company Type, Complement Drug Area Served and Its Competitors
Table 132. GenMab Complement Drug Product Offered
Table 133. GenMab Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 134. GenMab Main Business
Table 135. GenMab Latest Developments
Table 136. Akari Therapeutics Details, Company Type, Complement Drug Area Served and Its Competitors
Table 137. Akari Therapeutics Complement Drug Product Offered
Table 138. Akari Therapeutics Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 139. Akari Therapeutics Main Business
Table 140. Akari Therapeutics Latest Developments
Table 141. AbbVie Details, Company Type, Complement Drug Area Served and Its Competitors
Table 142. AbbVie Complement Drug Product Offered
Table 143. AbbVie Complement Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 144. AbbVie Main Business
Table 145. AbbVie Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Complement Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Complement Drug Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Complement Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Complement Drug Sales Market Share by Country/Region (2024)
Figure 8. Complement Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Complement Drug Market Size Market Share by Type in 2024
Figure 10. Complement Drug in Blood Disease
Figure 11. Global Complement Drug Market: Blood Disease (2020-2025) & ($ millions)
Figure 12. Complement Drug in Kidney Disease
Figure 13. Global Complement Drug Market: Kidney Disease (2020-2025) & ($ millions)
Figure 14. Complement Drug in Others
Figure 15. Global Complement Drug Market: Others (2020-2025) & ($ millions)
Figure 16. Global Complement Drug Market Size Market Share by Application in 2024
Figure 17. Global Complement Drug Revenue Market Share by Player in 2024
Figure 18. Global Complement Drug Market Size Market Share by Region (2020-2025)
Figure 19. Americas Complement Drug Market Size 2020-2025 ($ millions)
Figure 20. APAC Complement Drug Market Size 2020-2025 ($ millions)
Figure 21. Europe Complement Drug Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Complement Drug Market Size 2020-2025 ($ millions)
Figure 23. Americas Complement Drug Value Market Share by Country in 2024
Figure 24. United States Complement Drug Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Complement Drug Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Complement Drug Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Complement Drug Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Complement Drug Market Size Market Share by Region in 2024
Figure 29. APAC Complement Drug Market Size Market Share by Type (2020-2025)
Figure 30. APAC Complement Drug Market Size Market Share by Application (2020-2025)
Figure 31. China Complement Drug Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Complement Drug Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Complement Drug Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Complement Drug Market Size Growth 2020-2025 ($ millions)
Figure 35. India Complement Drug Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Complement Drug Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Complement Drug Market Size Market Share by Country in 2024
Figure 38. Europe Complement Drug Market Size Market Share by Type (2020-2025)
Figure 39. Europe Complement Drug Market Size Market Share by Application (2020-2025)
Figure 40. Germany Complement Drug Market Size Growth 2020-2025 ($ millions)
Figure 41. France Complement Drug Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Complement Drug Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Complement Drug Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Complement Drug Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Complement Drug Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Complement Drug Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Complement Drug Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Complement Drug Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Complement Drug Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Complement Drug Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Complement Drug Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Complement Drug Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Complement Drug Market Size 2026-2031 ($ millions)
Figure 54. APAC Complement Drug Market Size 2026-2031 ($ millions)
Figure 55. Europe Complement Drug Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Complement Drug Market Size 2026-2031 ($ millions)
Figure 57. United States Complement Drug Market Size 2026-2031 ($ millions)
Figure 58. Canada Complement Drug Market Size 2026-2031 ($ millions)
Figure 59. Mexico Complement Drug Market Size 2026-2031 ($ millions)
Figure 60. Brazil Complement Drug Market Size 2026-2031 ($ millions)
Figure 61. China Complement Drug Market Size 2026-2031 ($ millions)
Figure 62. Japan Complement Drug Market Size 2026-2031 ($ millions)
Figure 63. Korea Complement Drug Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Complement Drug Market Size 2026-2031 ($ millions)
Figure 65. India Complement Drug Market Size 2026-2031 ($ millions)
Figure 66. Australia Complement Drug Market Size 2026-2031 ($ millions)
Figure 67. Germany Complement Drug Market Size 2026-2031 ($ millions)
Figure 68. France Complement Drug Market Size 2026-2031 ($ millions)
Figure 69. UK Complement Drug Market Size 2026-2031 ($ millions)
Figure 70. Italy Complement Drug Market Size 2026-2031 ($ millions)
Figure 71. Russia Complement Drug Market Size 2026-2031 ($ millions)
Figure 72. Egypt Complement Drug Market Size 2026-2031 ($ millions)
Figure 73. South Africa Complement Drug Market Size 2026-2031 ($ millions)
Figure 74. Israel Complement Drug Market Size 2026-2031 ($ millions)
Figure 75. Turkey Complement Drug Market Size 2026-2031 ($ millions)
Figure 76. Global Complement Drug Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Complement Drug Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Complement Drug Market Size 2026-2031 ($ millions)